Skip to main content
Erschienen in: Rheumatology International 11/2019

23.09.2019 | Biomarkers

Delta-neutrophil index: a potential predictor of coronary artery involvement in Kawasaki disease by retrospective analysis

verfasst von: Sang Hun Lee, Kyung Ok Ko, Jae Woo Lim, Jung Min Yoon, Young Hwa Song, Jong Wook Lee, Eun Jung Cheon

Erschienen in: Rheumatology International | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

DNI is the immature granulocyte fraction provided by a blood cell analyzer, which is determined by subtracting the fraction of mature polymorphonuclear leukocytes from the sum of myeloperoxidase-reactive cells. We aimed to evaluate the role of Delta-neutrophil index (DNI) in cardiac prognosis prediction in children with Kawasaki disease (KD). Medical records of 193 patients were retrospectively reviewed. The values of DNI, white blood cells, erythrocyte sedimentation rate, the percent of polymorphonuclear leucocytes, C-reactive protein, aspartate transaminase, alanine aminotransferase, total bilirubin data of children with KD were analyzed. Also, sex and age of children were compared. The value of DNI was higher in children with cardiac complications [median 0.8 (0–0.26) vs 5.3 (3.55–8.95); P < 0.001]. The ROC curves showed that DNI was a better predictor of cardiac complications than other parameters. The best cutoff value for DNI to predict cardiac complications was 5.55% with sensitivity of 80% and specificity of 82% (AUC 0.883, 95% confidence interval [CI] 0.807–0.959, P < 0.05). DNI could serve as a facile and useful marker to predict cardiac complications in children with KD, as it is included in a routine complete blood count.
Literatur
1.
Zurück zum Zitat Onouchi Yoshihiro (2018) The genetics of Kawasaki disease. Int J Rheum Dis 21(1):26–30CrossRef Onouchi Yoshihiro (2018) The genetics of Kawasaki disease. Int J Rheum Dis 21(1):26–30CrossRef
2.
Zurück zum Zitat Ji Whan Han (2017) The efficacy and safety of high-dose intravenous immunoglobulin in the treatment of kawasaki disease: how can we predict resistance to intravenous immunoglobulin treatment of kawasaki disease? Korean Circ J 47(2):179–181CrossRef Ji Whan Han (2017) The efficacy and safety of high-dose intravenous immunoglobulin in the treatment of kawasaki disease: how can we predict resistance to intravenous immunoglobulin treatment of kawasaki disease? Korean Circ J 47(2):179–181CrossRef
3.
Zurück zum Zitat Burns JC, Franco A (2015) The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease. Expert Rev Clin Immunol 11(7):819–825CrossRef Burns JC, Franco A (2015) The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease. Expert Rev Clin Immunol 11(7):819–825CrossRef
4.
Zurück zum Zitat Kim Soo-Jin (2018) Risk factors related to coronary artery outcome in Kawasaki disease. Korean Circ J 48(4):329–331CrossRef Kim Soo-Jin (2018) Risk factors related to coronary artery outcome in Kawasaki disease. Korean Circ J 48(4):329–331CrossRef
5.
Zurück zum Zitat Egami K, Muta H, Ishii M et al (2006) Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149(2):237–240CrossRef Egami K, Muta H, Ishii M et al (2006) Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149(2):237–240CrossRef
6.
Zurück zum Zitat Kobayashi T, Inoue Y, Morikawa A (2008) Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease. Nihon Rinsho. Jpn J Clin Med 66(2):332–337 Kobayashi T, Inoue Y, Morikawa A (2008) Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease. Nihon Rinsho. Jpn J Clin Med 66(2):332–337
7.
Zurück zum Zitat Newburger JW, Takahashi M, Gerber MA et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114(6):1708–1733CrossRef Newburger JW, Takahashi M, Gerber MA et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114(6):1708–1733CrossRef
8.
Zurück zum Zitat Ministry of Health and Welfare, Research Committee on Kawasaki Disease (1984) Report of the subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo Ministry of Health and Welfare, Research Committee on Kawasaki Disease (1984) Report of the subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo
9.
Zurück zum Zitat Kratz A, Maloum K, O’Malley C et al (2006) Enumeration of nucleated red blood cells with the ADVIA 2120 hematology system: an international multicenter clinical trial. Lab Hematol 12(2):63–70CrossRef Kratz A, Maloum K, O’Malley C et al (2006) Enumeration of nucleated red blood cells with the ADVIA 2120 hematology system: an international multicenter clinical trial. Lab Hematol 12(2):63–70CrossRef
10.
Zurück zum Zitat Lee Hye Young, Song Min Seob (2016) Serum NT-pro BNP levels and PMN percentage were significantly elevated in patients with KD with IVIG resistance and CAL. Korean J Pediatr 59(12):477–482CrossRef Lee Hye Young, Song Min Seob (2016) Serum NT-pro BNP levels and PMN percentage were significantly elevated in patients with KD with IVIG resistance and CAL. Korean J Pediatr 59(12):477–482CrossRef
11.
Zurück zum Zitat Jun H, Ko KO, Lim JW et al (2016) Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in Kawasaki disease. Korean J Pediatr 59(7):298–302CrossRef Jun H, Ko KO, Lim JW et al (2016) Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in Kawasaki disease. Korean J Pediatr 59(7):298–302CrossRef
12.
Zurück zum Zitat Ha K-S, Lee J, Jang GJ et al (2015) Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease. Am J Cardiol 116(2):301–306CrossRef Ha K-S, Lee J, Jang GJ et al (2015) Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease. Am J Cardiol 116(2):301–306CrossRef
13.
Zurück zum Zitat Kobayashi T, Inoue Y, Takeuchi K et al (2006) Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113:2606–2612CrossRef Kobayashi T, Inoue Y, Takeuchi K et al (2006) Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113:2606–2612CrossRef
14.
Zurück zum Zitat Muta H, Ishii M, Furui J et al (2006) Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease. Acta Paediatr 95(2):189–193CrossRef Muta H, Ishii M, Furui J et al (2006) Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease. Acta Paediatr 95(2):189–193CrossRef
15.
Zurück zum Zitat Song D, Yeo Y, Ha K et al (2009) Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age. Eur J Pediatr 168(11):1315–1321CrossRef Song D, Yeo Y, Ha K et al (2009) Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age. Eur J Pediatr 168(11):1315–1321CrossRef
16.
Zurück zum Zitat Nakamura Y, Yashiro M, Uehara R et al (2004) Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 46(1):33–38CrossRef Nakamura Y, Yashiro M, Uehara R et al (2004) Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 46(1):33–38CrossRef
17.
Zurück zum Zitat Cornbleet PJ (2002) Clinical utility of the band count. Clin Lab Med 22(1):101–136CrossRef Cornbleet PJ (2002) Clinical utility of the band count. Clin Lab Med 22(1):101–136CrossRef
18.
Zurück zum Zitat Kim HW, Ku S, Jeong SJ et al (2012) Delta neutrophil index: could it predict mortality in patients with bacteremia? Scand J Infect Dis 44(7):475–480CrossRef Kim HW, Ku S, Jeong SJ et al (2012) Delta neutrophil index: could it predict mortality in patients with bacteremia? Scand J Infect Dis 44(7):475–480CrossRef
19.
Zurück zum Zitat Seok Y, Choi JR, Kim J et al (2012) Delta neutrophil index: a promising diagnostic and prognostic marker for sepsis. Shock 37(3):242–246CrossRef Seok Y, Choi JR, Kim J et al (2012) Delta neutrophil index: a promising diagnostic and prognostic marker for sepsis. Shock 37(3):242–246CrossRef
20.
Zurück zum Zitat Nahm CH, Choi JW, Lee JW (2008) Delta neutrophil index in automated immature granulocyte counts for assessing disease severity of patients with sepsis. Ann Clin Lab Sci 38(3):241–246PubMed Nahm CH, Choi JW, Lee JW (2008) Delta neutrophil index in automated immature granulocyte counts for assessing disease severity of patients with sepsis. Ann Clin Lab Sci 38(3):241–246PubMed
21.
Zurück zum Zitat Lee SM, Eun HS, Namgung R et al (2013) Usefulness of the delta neutrophil index for assessing neonatal sepsis. Acta Paediatr 102(1):e13–e16CrossRef Lee SM, Eun HS, Namgung R et al (2013) Usefulness of the delta neutrophil index for assessing neonatal sepsis. Acta Paediatr 102(1):e13–e16CrossRef
22.
Zurück zum Zitat Kong T, Kim TH, Park YS et al (2017) Usefulness of the delta neutrophil index to predict 30-day mortality in patients with ST segment elevation myocardial infarction. Sci Rep 7(1):15718CrossRef Kong T, Kim TH, Park YS et al (2017) Usefulness of the delta neutrophil index to predict 30-day mortality in patients with ST segment elevation myocardial infarction. Sci Rep 7(1):15718CrossRef
Metadaten
Titel
Delta-neutrophil index: a potential predictor of coronary artery involvement in Kawasaki disease by retrospective analysis
verfasst von
Sang Hun Lee
Kyung Ok Ko
Jae Woo Lim
Jung Min Yoon
Young Hwa Song
Jong Wook Lee
Eun Jung Cheon
Publikationsdatum
23.09.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 11/2019
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-019-04448-9

Weitere Artikel der Ausgabe 11/2019

Rheumatology International 11/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.